| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:31844926; PMID:32525701 |
| GO:0000080 | Mitotic g1 phase | Affects phenotype | PMID:34364923 |
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:31822296; PMID:34364923; PMID:35809665 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:34364923; PMID:35809665; PMID:36162444 |
| GO:0000104 | Succinate dehydrogenase activity | Decreases phenotype | PMID:36947368 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:31822296 |
| GO:0000381 | Regulation of alternative mrna splicing, via spliceosome | Affects phenotype | PMID:35072517 |
| GO:0000723 | Telomere maintenance | Decreases phenotype | PMID:27084675 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:25062976; PMID:35513056; PMID:35809665; PMID:38723480 |
| GO:0000932 | P-body | Increases phenotype | PMID:34952004 |
| GO:0001510 | Rna methylation | Affects phenotype | PMID:37061066 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:36068745 |
| GO:0001568 | Blood vessel development | Affects phenotype | PMID:23757599 |
| GO:0001692 | Histamine metabolic process | Affects phenotype | PMID:37888683 |
| GO:0001774 | Microglial cell activation | Increases phenotype | PMID:35777461 |
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:38310360 |
| GO:0001819 | Positive regulation of cytokine production | Increases phenotype | PMID:17267001 |
| GO:0001825 | Blastocyst formation | Decreases phenotype | PMID:9820195 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:36117518; PMID:36947368 |
| GO:0001837 | Epithelial to mesenchymal transition | Increases phenotype | PMID:32645460; PMID:33396024; PMID:39818140 |
| GO:0001887 | Selenium compound metabolic process | Affects phenotype | PMID:29398653 |
| GO:0001890 | Placenta development | Affects phenotype | PMID:25304211 |
| GO:0001894 | Tissue homeostasis | Decreases phenotype | PMID:31309260 |
| GO:0001951 | Intestinal d-glucose absorption | Increases phenotype | PMID:22354675 |
| GO:0001954 | Positive regulation of cell-matrix adhesion | Decreases phenotype | PMID:28829631 |
| GO:0002027 | Regulation of heart rate | Affects phenotype | PMID:26988683 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Decreases phenotype | PMID:31051324 |
| GO:0002455 | Humoral immune response mediated by circulating immunoglobulin | Decreases phenotype | PMID:31051324 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:25062976; PMID:25062976; PMID:36528894; PMID:30889423; PMID:35598369; PMID:36528894; PMID:36689145; PMID:36822304; PMID:38229313; PMID:38881217; PMID:38909693; PMID:38945390; PMID:39317010; PMID:39657381 |
| GO:0002534 | Cytokine production involved in inflammatory response | Affects phenotype | PMID:31775542 |
| GO:0002681 | Somatic recombination of t cell receptor gene segments | Decreases phenotype | PMID:29757418 |
| GO:0002698 | Negative regulation of immune effector process | Increases phenotype | PMID:34953898 |
| GO:0002923 | Regulation of humoral immune response mediated by circulating immunoglobulin | Affects phenotype | PMID:32276596 |
| GO:0003073 | Regulation of systemic arterial blood pressure | Affects phenotype | PMID:28270149 |
| GO:0003094 | Glomerular filtration | Decreases phenotype | PMID:33603096 |
| GO:0003104 | Positive regulation of glomerular filtration | Increases phenotype | PMID:31326826 |
| GO:0003330 | Regulation of extracellular matrix constituent secretion | Affects phenotype | PMID:32647881 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:35307918 |
| GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:38676876 |
| GO:0004035 | Alkaline phosphatase activity | Affects phenotype | PMID:21740555; PMID:25062976; PMID:25062976; PMID:30324125; PMID:30324125; PMID:33026618; PMID:35307918 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:25062976; PMID:25062976; PMID:30324125; PMID:30324125; PMID:31584213; PMID:31584213; PMID:32402895; PMID:33026618; PMID:38229313; PMID:32402895; PMID:33026618; PMID:33609566; PMID:36689145; PMID:38229313; PMID:39079579 |
| GO:0004096 | Catalase activity | Decreases phenotype | PMID:37730986; PMID:38881217 |
| GO:0004111 | Creatine kinase activity | Increases phenotype | PMID:31584213 |
| GO:0004126 | Cytidine deaminase activity | Increases phenotype | PMID:34998823 |
| GO:0004197 | Cysteine-type endopeptidase activity | Increases phenotype | PMID:33497711 |
| GO:0004198 | Calcium-dependent cysteine-type endopeptidase activity | Decreases phenotype | PMID:31398423 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:25062976; PMID:31350662; PMID:31350662; PMID:33410021; PMID:32270456; PMID:33171135; PMID:36757007; PMID:33410021; PMID:36528894; PMID:36757007 |
| GO:0004457 | Lactate dehydrogenase activity | Affects phenotype | PMID:25062976; PMID:31584213; PMID:31584213; PMID:32402895; PMID:32402895; PMID:35714946 |
| GO:0004601 | Peroxidase activity | Decreases phenotype | PMID:36850985 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:25062976; PMID:31584213; PMID:31584213; PMID:37906532; PMID:32270456; PMID:32402895; PMID:33127376; PMID:35714946; PMID:36689145; PMID:36813806; PMID:36822304; PMID:37906532; PMID:38945390 |
| GO:0004611 | Phosphoenolpyruvate carboxykinase activity | Increases phenotype | PMID:32226249 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:25062976; PMID:25062976; PMID:36850985; PMID:27289040; PMID:29741077; PMID:30324125; PMID:31350662; PMID:31350662; PMID:33148380; PMID:31584213; PMID:31584213; PMID:37906532; PMID:31739468; PMID:32270456; PMID:32402895; PMID:33127376; PMID:33171135; PMID:33410021; PMID:35307918; PMID:35714946; PMID:35809665; PMID:36528894; PMID:36689145; PMID:36757007; PMID:36813806; PMID:36822304; PMID:36850985; PMID:37084658; PMID:37730986; PMID:37879473; PMID:37906532; PMID:38881217; PMID:38909693 |
| GO:0005388 | P-type calcium transporter activity | Decreases phenotype | PMID:25062976 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:25062976 |
| GO:0005776 | Autophagosome | Increases phenotype | PMID:38734222 |
| GO:0005975 | Carbohydrate metabolic process | Affects phenotype | PMID:37888683 |
| GO:0005977 | Glycogen metabolic process | Affects phenotype | PMID:38945390 |
| GO:0005988 | Lactose metabolic process | Affects phenotype | PMID:38945390 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:33736254; PMID:36509832; PMID:38945390; PMID:39098089 |
| GO:0006071 | Glycerol metabolic process | Affects phenotype | PMID:33736254 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:32006662 |
| GO:0006096 | Glycolytic process | Increases phenotype | PMID:35625704 |
| GO:0006099 | Tricarboxylic acid cycle | Affects phenotype | PMID:25577196 |
| GO:0006102 | Isocitrate metabolic process | Decreases phenotype | PMID:24295472 |
| GO:0006119 | Oxidative phosphorylation | Affects phenotype | PMID:35625704; PMID:36947368 |
| GO:0006260 | Dna replication | Decreases phenotype | PMID:35714946 |
| GO:0006264 | Mitochondrial dna replication | Affects phenotype | PMID:38676876 |
| GO:0006281 | Dna repair | Decreases phenotype | PMID:16882524; PMID:17450239; PMID:31769258 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:34998823; PMID:35490796; PMID:35809665; PMID:36689145; PMID:36947368; PMID:39922519 |
| GO:0006306 | Dna methylation | Decreases phenotype | PMID:26771251; PMID:28436716; PMID:29940200 |
| GO:0006308 | Dna catabolic process | Increases phenotype | PMID:34998823; PMID:35821281 |
| GO:0006355 | Regulation of dna-templated transcription | Affects phenotype | PMID:28927277; PMID:31864032 |
| GO:0006417 | Regulation of translation | Affects phenotype | PMID:28927277 |
| GO:0006493 | Protein o-linked glycosylation | Increases phenotype | PMID:38734222 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:32645460 |
| GO:0006518 | Peptide metabolic process | Affects phenotype | PMID:37888683 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:37759824; PMID:37888683 |
| GO:0006534 | Cysteine metabolic process | Affects phenotype | PMID:38676876 |
| GO:0006544 | Glycine metabolic process | Affects phenotype | PMID:33736254 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:32062438 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:39317010 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:33736254; PMID:36463740; PMID:36813806; PMID:37906532; PMID:38945390 |
| GO:0006644 | Phospholipid metabolic process | Increases phenotype | PMID:37759824; PMID:37906532 |
| GO:0006739 | Nadp metabolic process | Affects phenotype | PMID:38945390 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:24295472; PMID:25062976; PMID:25062976; PMID:36850985; PMID:31350662; PMID:31584213; PMID:37906532; PMID:33026618; PMID:33026618; PMID:36822304; PMID:33410021; PMID:33497711; PMID:33736254; PMID:35307918; PMID:35598369; PMID:35809665; PMID:36528894; PMID:36813806; PMID:36822304; PMID:36850985; PMID:37482551; PMID:37676925; PMID:37730986; PMID:37879473; PMID:37906532; PMID:38881217; PMID:39317010 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:26989453; PMID:27289040; PMID:29741077; PMID:30324125 |
| GO:0006801 | Superoxide metabolic process | Decreases phenotype | PMID:38229313 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:25194983 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:27289040 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:37879473 |
| GO:0006887 | Exocytosis | Affects phenotype | PMID:37527016 |
| GO:0006909 | Phagocytosis | Affects phenotype | PMID:33063558; PMID:35777461 |
| GO:0006911 | Phagocytosis, engulfment | Increases phenotype | PMID:35351628 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:32645460 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:23600209; PMID:23600209; PMID:39693001; PMID:24212999; PMID:25227780; PMID:27289040; PMID:31822296; PMID:32179164; PMID:32188015; PMID:32802178; PMID:33921748; PMID:34364923; PMID:35714946; PMID:36117518; PMID:36861143; PMID:37906532; PMID:38299738 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:29741077; PMID:30889423; PMID:31309260; PMID:37906532; PMID:39317010 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:20547570; PMID:23301828; PMID:30324125; PMID:31350662; PMID:32031413; PMID:32031413; PMID:33378118; PMID:32402895; PMID:33378118; PMID:33410021 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:18053222; PMID:21219961 |
| GO:0006997 | Nucleus organization | Decreases phenotype | PMID:36689145 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:37879473; PMID:38157908 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:35714946 |
| GO:0007029 | Endoplasmic reticulum organization | Affects phenotype | PMID:39317010 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:25062976; PMID:32735129; PMID:38157908 |
| GO:0007042 | Lysosomal lumen acidification | Affects phenotype | PMID:35809665 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:36068745 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:22776062; PMID:33127376; PMID:36757007; PMID:36813806; PMID:37084658; PMID:38798119 |
| GO:0007286 | Spermatid development | Affects phenotype | PMID:34352348; PMID:38798119 |
| GO:0007346 | Regulation of mitotic cell cycle | Increases phenotype | PMID:32159786 |
| GO:0007420 | Brain development | Decreases phenotype | PMID:20829427 |
| GO:0007567 | Parturition | Affects phenotype | PMID:25304211 |
| GO:0007610 | Behavior | Affects phenotype | PMID:33154986 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:28903487 |
| GO:0007612 | Learning | Decreases phenotype | PMID:29233033; PMID:35351628; PMID:35993674 |
| GO:0007613 | Memory | Decreases phenotype | PMID:26713676; PMID:29233033; PMID:35351628; PMID:35993674; PMID:37482551 |
| GO:0007625 | Grooming behavior | Increases phenotype | PMID:38056122 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:37676925 |
| GO:0008016 | Regulation of heart contraction | Affects phenotype | PMID:17520054 |
| GO:0008065 | Establishment of blood-nerve barrier | Affects phenotype | PMID:33739591 |
| GO:0008121 | Ubiquinol-cytochrome-c reductase activity | Increases phenotype | PMID:37906532 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:37906532 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:20670920; PMID:29329102; PMID:31309260; PMID:37131019 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:37906532 |
| GO:0008202 | Steroid metabolic process | Affects phenotype | PMID:37888683 |
| GO:0008203 | Cholesterol metabolic process | Increases phenotype | PMID:33127376; PMID:36813806; PMID:37906532; PMID:38945390; PMID:39317010 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:38945390; PMID:39317010 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:36068745 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:17164464; PMID:33488031; PMID:21878420; PMID:23222207; PMID:24218149; PMID:26220686; PMID:35598369 |
| GO:0008219 | Cell death | Increases phenotype | PMID:31542844; PMID:33497711; PMID:39720976 |
| GO:0008270 | Zinc ion binding | Decreases phenotype | PMID:33149232 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:23942117; PMID:27289040; PMID:32802178; PMID:33047385; PMID:34364923; PMID:35378173; PMID:35523338; PMID:35714946; PMID:37061066; PMID:38299738; PMID:38881217; PMID:38909693 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:23100159; PMID:25273566; PMID:25586904; PMID:25868784 |
| GO:0008286 | Insulin receptor signaling pathway | Decreases phenotype | PMID:39657381 |
| GO:0008291 | Acetylcholine metabolic process | Affects phenotype | PMID:29233033 |
| GO:0008483 | Transaminase activity | Increases phenotype | PMID:21740555; PMID:29334960 |
| GO:0009060 | Aerobic respiration | Decreases phenotype | PMID:24295472; PMID:32045263 |
| GO:0009235 | Cobalamin metabolic process | Affects phenotype | PMID:32402895 |
| GO:0009299 | Mrna transcription | Affects phenotype | PMID:27838757; PMID:28927277 |
| GO:0009308 | Amine metabolic process | Affects phenotype | PMID:37759824; PMID:37888683 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Increases phenotype | PMID:23073540; PMID:31135185; PMID:25304211; PMID:25325195; PMID:26771251; PMID:29247444; PMID:32603190; PMID:35747940; PMID:39425535 |
| GO:0010467 | Gene expression | Decreases phenotype | PMID:17450239; PMID:17938729; PMID:18288317; PMID:18414638; PMID:24936443; PMID:25759245; PMID:28069514; PMID:30819207; PMID:31752878 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:18039032; PMID:35646058; PMID:36428691; PMID:36617169 |
| GO:0010507 | Negative regulation of autophagy | Increases phenotype | PMID:29248574 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:25868784 |
| GO:0010718 | Positive regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:25586904 |
| GO:0010833 | Telomere maintenance via telomere lengthening | Increases phenotype | PMID:22917110 |
| GO:0010866 | Regulation of triglyceride biosynthetic process | Affects phenotype | PMID:39098089 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:24295472 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:29248574 |
| GO:0014002 | Astrocyte development | Decreases phenotype | PMID:20829427 |
| GO:0014005 | Microglia development | Affects phenotype | PMID:35777461 |
| GO:0015444 | P-type magnesium transporter activity | Decreases phenotype | PMID:25062976 |
| GO:0015700 | Arsenite transport | Increases phenotype | PMID:29864931 |
| GO:0015723 | Bilirubin transport | Decreases phenotype | PMID:36720308 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:27289040; PMID:29741077; PMID:30324125; PMID:31350662; PMID:31350662; PMID:33148380; PMID:31584213; PMID:31739468; PMID:32270456; PMID:32402895; PMID:33026618; PMID:33127376; PMID:33148380; PMID:33410021; PMID:35307918; PMID:35714946; PMID:39098089 |
| GO:0016049 | Cell growth | Affects phenotype | PMID:31822296; PMID:32045263 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:25559853; PMID:36861143; PMID:38157908 |
| GO:0018119 | Peptidyl-cysteine s-nitrosylation | Decreases phenotype | PMID:25110733 |
| GO:0018126 | Protein hydroxylation | Increases phenotype | PMID:33026618 |
| GO:0018158 | Protein oxidation | Affects phenotype | PMID:24348802; PMID:25062976; PMID:31584213; PMID:33410021; PMID:36757007 |
| GO:0019530 | Taurine metabolic process | Affects phenotype | PMID:33736254 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:33026618; PMID:33026618; PMID:36822304; PMID:36822304; PMID:37879473; PMID:38945390 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:37888683 |
| GO:0019852 | L-ascorbic acid metabolic process | Affects phenotype | PMID:25062976; PMID:31584213; PMID:33736254 |
| GO:0020027 | Hemoglobin metabolic process | Affects phenotype | PMID:37759824 |
| GO:0022602 | Ovulation cycle process | Affects phenotype | PMID:36068745 |
| GO:0030097 | Hemopoiesis | Affects phenotype | PMID:38945390 |
| GO:0030154 | Cell differentiation | Affects phenotype | PMID:37999580; PMID:38299738 |
| GO:0030199 | Collagen fibril organization | Affects phenotype | PMID:33026618; PMID:37999580; PMID:38676876 |
| GO:0030218 | Erythrocyte differentiation | Affects phenotype | PMID:33149232 |
| GO:0030219 | Megakaryocyte differentiation | Decreases phenotype | PMID:33149232 |
| GO:0030220 | Platelet formation | Decreases phenotype | PMID:31991237 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:36822304; PMID:39693001 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:23100159; PMID:25273566 |
| GO:0030578 | Pml body organization | Decreases phenotype | PMID:36880596 |
| GO:0030877 | Beta-catenin destruction complex | Affects phenotype | PMID:39818140 |
| GO:0031012 | Extracellular matrix | Increases phenotype | PMID:37999580 |
| GO:0031987 | Locomotion involved in locomotory behavior | Decreases phenotype | PMID:29233033; PMID:29233033; PMID:38056122 |
| GO:0032042 | Mitochondrial dna metabolic process | Affects phenotype | PMID:29940200 |
| GO:0032060 | Bleb assembly | Increases phenotype | PMID:36117518 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:31350662 |
| GO:0032259 | Methylation | Affects phenotype | PMID:18288317 |
| GO:0032350 | Regulation of hormone metabolic process | Affects phenotype | PMID:18414639 |
| GO:0032507 | Maintenance of protein location in cell | Affects phenotype | PMID:31309260 |
| GO:0032611 | Interleukin-1 beta production | Affects phenotype | PMID:20940111 |
| GO:0032636 | Interleukin-7 production | Decreases phenotype | PMID:19167470 |
| GO:0032680 | Regulation of tumor necrosis factor production | Affects phenotype | PMID:31652851 |
| GO:0032729 | Positive regulation of type ii interferon production | Affects phenotype | PMID:20940111 |
| GO:0032760 | Positive regulation of tumor necrosis factor production | Increases phenotype | PMID:20940111; PMID:29028684; PMID:31652851; PMID:7537211 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:7537211 |
| GO:0032964 | Collagen biosynthetic process | Increases phenotype | PMID:31238026 |
| GO:0033209 | Tumor necrosis factor-mediated signaling pathway | Affects phenotype | PMID:24675094 |
| GO:0033327 | Leydig cell differentiation | Affects phenotype | PMID:33171135 |
| GO:0033590 | Response to cobalamin | Increases phenotype | PMID:29459232 |
| GO:0033962 | P-body assembly | Increases phenotype | PMID:34952004 |
| GO:0034109 | Homotypic cell-cell adhesion | Increases phenotype | PMID:36504884 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:24295472; PMID:24348802; PMID:25062976; PMID:25062976; PMID:36850985; PMID:35598369; PMID:35809665; PMID:36669534; PMID:36689145; PMID:36822304; PMID:36850985; PMID:36947368; PMID:37676925; PMID:37730986; PMID:37759824; PMID:37879473; PMID:37906532; PMID:38229313; PMID:38723480; PMID:38881217; PMID:38909693; PMID:38945390; PMID:39317010; PMID:39922519 |
| GO:0034599 | Cellular response to oxidative stress | Affects phenotype | PMID:20940111 |
| GO:0035459 | Vesicle cargo loading | Affects phenotype | PMID:30169766 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:29233033; PMID:29233033; PMID:38056122 |
| GO:0035641 | Locomotory exploration behavior | Affects phenotype | PMID:33609566 |
| GO:0035733 | Hepatic stellate cell activation | Increases phenotype | PMID:37999580 |
| GO:0035773 | Insulin secretion involved in cellular response to glucose stimulus | Decreases phenotype | PMID:23349674 |
| GO:0035794 | Positive regulation of mitochondrial membrane permeability | Increases phenotype | PMID:24295472 |
| GO:0035855 | Megakaryocyte development | Increases phenotype | PMID:33149232 |
| GO:0035934 | Corticosterone secretion | Increases phenotype | PMID:24218149 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:33171135 |
| GO:0035937 | Estrogen secretion | Affects phenotype | PMID:36068745 |
| GO:0036123 | Histone h3-k9 dimethylation | Affects phenotype | PMID:32062438; PMID:33378118 |
| GO:0036126 | Sperm flagellum | Affects phenotype | PMID:38798119 |
| GO:0036145 | Dendritic cell homeostasis | Affects phenotype | PMID:30889423 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:38676876 |
| GO:0036374 | Glutathione hydrolase activity | Increases phenotype | PMID:25062976 |
| GO:0038001 | Paracrine signaling | Affects phenotype | PMID:37527016 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:24348802 |
| GO:0040029 | Epigenetic regulation of gene expression | Affects phenotype | PMID:38030093 |
| GO:0042116 | Macrophage activation | Affects phenotype | PMID:36617169 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:35598369 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:35598369 |
| GO:0042332 | Gravitaxis | Affects phenotype | PMID:33609566 |
| GO:0042360 | Vitamin e metabolic process | Affects phenotype | PMID:25062976 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:38797200 |
| GO:0042428 | Serotonin metabolic process | Affects phenotype | PMID:37888683 |
| GO:0042431 | Indole metabolic process | Affects phenotype | PMID:37888683 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:33026618 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:22354675; PMID:27623387 |
| GO:0042696 | Menarche | Affects phenotype | PMID:36729392 |
| GO:0042742 | Defense response to bacterium | Increases phenotype | PMID:33063558 |
| GO:0042743 | Hydrogen peroxide metabolic process | Affects phenotype | PMID:35714946; PMID:36850985 |
| GO:0042755 | Eating behavior | Affects phenotype | PMID:25062976 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:25062976; PMID:29741077; PMID:37676925 |
| GO:0043005 | Neuron projection | Decreases phenotype | PMID:37624150 |
| GO:0043045 | Dna methylation involved in embryo development | Affects phenotype | PMID:24525453 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:20829427; PMID:24028894; PMID:25868784 |
| GO:0043373 | Cd4-positive, alpha-beta t cell lineage commitment | Decreases phenotype | PMID:24525453 |
| GO:0043374 | Cd8-positive, alpha-beta t cell differentiation | Increases phenotype | PMID:23757598 |
| GO:0043375 | Cd8-positive, alpha-beta t cell lineage commitment | Increases phenotype | PMID:24525453 |
| GO:0043403 | Skeletal muscle tissue regeneration | Decreases phenotype | PMID:37527016 |
| GO:0043473 | Pigmentation | Increases phenotype | PMID:27966667 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:28903487 |
| GO:0043588 | Skin development | Affects phenotype | PMID:38299738 |
| GO:0043616 | Keratinocyte proliferation | Decreases phenotype | PMID:38299738 |
| GO:0043970 | Histone h3-k9 acetylation | Increases phenotype | PMID:39617304 |
| GO:0043971 | Histone h3-k18 acetylation | Affects phenotype | PMID:27068294; PMID:32031413; PMID:37999580 |
| GO:0043984 | Histone h4-k16 acetylation | Decreases phenotype | PMID:32735129 |
| GO:0044026 | Dna hypermethylation | Increases phenotype | PMID:25598836 |
| GO:0044027 | Hypermethylation of cpg island | Increases phenotype | PMID:28242323; PMID:38030093 |
| GO:0044028 | Dna hypomethylation | Increases phenotype | PMID:28270149 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:22466225; PMID:22551203; PMID:25304211; PMID:27838757; PMID:28927277 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:31542844; PMID:31739468; PMID:31739468; PMID:33736254; PMID:32031413; PMID:32188015; PMID:32188015; PMID:32735129; PMID:32930475; PMID:33049506; PMID:33396024; PMID:33736254; PMID:34998823; PMID:35714946; PMID:35809665; PMID:36669534; PMID:36861143; PMID:37730986; PMID:37879473; PMID:38056122; PMID:38157908; PMID:38299738; PMID:38723480; PMID:39693001 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:33396024; PMID:34364923; PMID:38299738; PMID:39818140; PMID:39922519 |
| GO:0044381 | Glucose import in response to insulin stimulus | Decreases phenotype | PMID:39098089 |
| GO:0044403 | Biological process involved in symbiotic interaction | Affects phenotype | PMID:31309260 |
| GO:0044546 | Nlrp3 inflammasome complex assembly | Increases phenotype | PMID:39657381 |
| GO:0044648 | Histone h3-k4 dimethylation | Increases phenotype | PMID:21385672 |
| GO:0044754 | Autolysosome | Increases phenotype | PMID:38734222 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:31822296; PMID:35809665 |
| GO:0045066 | Regulatory t cell differentiation | Increases phenotype | PMID:32735129 |
| GO:0045087 | Innate immune response | Affects phenotype | PMID:31703545 |
| GO:0045088 | Regulation of innate immune response | Affects phenotype | PMID:32514536 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:24295472 |
| GO:0045444 | Fat cell differentiation | Decreases phenotype | PMID:36989998 |
| GO:0045445 | Myoblast differentiation | Decreases phenotype | PMID:32159786 |
| GO:0045454 | Cell redox homeostasis | Affects phenotype | PMID:25868784; PMID:31309260 |
| GO:0045739 | Positive regulation of dna repair | Decreases phenotype | PMID:24473091 |
| GO:0045747 | Positive regulation of notch signaling pathway | Increases phenotype | PMID:32647881 |
| GO:0045793 | Positive regulation of cell size | Increases phenotype | PMID:39098089 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:25868784 |
| GO:0046007 | Negative regulation of activated t cell proliferation | Increases phenotype | PMID:28823652 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:25062976; PMID:31584213; PMID:33497711 |
| GO:0046085 | Adenosine metabolic process | Affects phenotype | PMID:37888683 |
| GO:0046108 | Uridine metabolic process | Affects phenotype | PMID:33736254 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:25062976; PMID:31584213; PMID:35351628; PMID:35351628; PMID:35777461; PMID:35777461; PMID:37676925; PMID:37730986 |
| GO:0046323 | Glucose import | Increases phenotype | PMID:32006662 |
| GO:0046415 | Urate metabolic process | Decreases phenotype | PMID:24348802; PMID:33026618 |
| GO:0046449 | Creatinine metabolic process | Decreases phenotype | PMID:24348802; PMID:32270456; PMID:32402895; PMID:32402895; PMID:33026618; PMID:36822304; PMID:33026618; PMID:33026618; PMID:36822304; PMID:36822304; PMID:37879473; PMID:38945390 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:21219961 |
| GO:0046483 | Heterocycle metabolic process | Affects phenotype | PMID:37888683 |
| GO:0046618 | Xenobiotic export from cell | Decreases phenotype | PMID:28458011 |
| GO:0046655 | Folic acid metabolic process | Affects phenotype | PMID:32402895 |
| GO:0046685 | Response to arsenic-containing substance | Increases phenotype | PMID:27561292; PMID:27713174; PMID:28494415; PMID:30889423; PMID:34272803; PMID:36399430; PMID:36850985; PMID:37797956; PMID:39675543 |
| GO:0046902 | Regulation of mitochondrial membrane permeability | Affects phenotype | PMID:36117518 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:39693001 |
| GO:0048266 | Behavioral response to pain | Decreases phenotype | PMID:33739591 |
| GO:0048538 | Thymus development | Decreases phenotype | PMID:19167470 |
| GO:0048589 | Developmental growth | Decreases phenotype | PMID:35646058 |
| GO:0048666 | Neuron development | Affects phenotype | PMID:37624150 |
| GO:0048864 | Stem cell development | Increases phenotype | PMID:33047385 |
| GO:0048866 | Stem cell fate specification | Increases phenotype | PMID:32062438 |
| GO:0050691 | Regulation of defense response to virus by host | Affects phenotype | PMID:32514536 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:20940111; PMID:25288670 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:17450237; PMID:17805430; PMID:25288670; PMID:26968381 |
| GO:0050966 | Detection of mechanical stimulus involved in sensory perception of pain | Decreases phenotype | PMID:33739591 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:38423337 |
| GO:0051027 | Dna transport | Increases phenotype | PMID:33063558 |
| GO:0051148 | Negative regulation of muscle cell differentiation | Increases phenotype | PMID:32647881 |
| GO:0051450 | Myoblast proliferation | Increases phenotype | PMID:32159786 |
| GO:0051452 | Intracellular ph reduction | Decreases phenotype | PMID:32525701 |
| GO:0051480 | Regulation of cytosolic calcium ion concentration | Affects phenotype | PMID:28823652 |
| GO:0051562 | Negative regulation of mitochondrial calcium ion concentration | Increases phenotype | PMID:24295472 |
| GO:0051593 | Response to folic acid | Decreases phenotype | PMID:25885259 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:27289040; PMID:32006662; PMID:32159786; PMID:35809665; PMID:36813806; PMID:38723480 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:31739468; PMID:33497711 |
| GO:0051897 | Positive regulation of protein kinase b signaling | Increases phenotype | PMID:25586904 |
| GO:0051899 | Membrane depolarization | Increases phenotype | PMID:36117518 |
| GO:0055001 | Muscle cell development | Decreases phenotype | PMID:37527016 |
| GO:0055072 | Iron ion homeostasis | Affects phenotype | PMID:37879473; PMID:38676876 |
| GO:0055088 | Lipid homeostasis | Decreases phenotype | PMID:24295472 |
| GO:0060013 | Righting reflex | Affects phenotype | PMID:33609566 |
| GO:0060208 | Proestrus | Affects phenotype | PMID:36068745 |
| GO:0060307 | Regulation of ventricular cardiac muscle cell membrane repolarization | Affects phenotype | PMID:19957052 |
| GO:0060322 | Head development | Decreases phenotype | PMID:25304211; PMID:25971349; PMID:26955061 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:32645460; PMID:33047385; PMID:34364923; PMID:39818140; PMID:39922519 |
| GO:0060348 | Bone development | Decreases phenotype | PMID:30696509 |
| GO:0060574 | Intestinal epithelial cell maturation | Affects phenotype | PMID:38310360 |
| GO:0060612 | Adipose tissue development | Increases phenotype | PMID:32045263; PMID:39098089 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:33127376; PMID:36813806 |
| GO:0061518 | Microglial cell proliferation | Increases phenotype | PMID:35777461 |
| GO:0061827 | Sperm head | Affects phenotype | PMID:38798119 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:25062976; PMID:25062976; PMID:36528894; PMID:32270456; PMID:36528894; PMID:37906532; PMID:38229313; PMID:39317010; PMID:39657381 |
| GO:0070577 | Lysine-acetylated histone binding | Affects phenotype | PMID:32031413; PMID:37999580 |
| GO:0070584 | Mitochondrion morphogenesis | Affects phenotype | PMID:32647881 |
| GO:0070814 | Hydrogen sulfide biosynthetic process | Affects phenotype | PMID:37482551 |
| GO:0070885 | Negative regulation of calcineurin-nfat signaling cascade | Increases phenotype | PMID:28823652 |
| GO:0070994 | Detection of oxidative stress | Affects phenotype | PMID:20587388; PMID:20587388; PMID:25062976; PMID:24936443; PMID:25062976; PMID:31309260; PMID:35598369; PMID:35821281; PMID:36813806; PMID:36822304; PMID:37084658; PMID:37759824; PMID:38229313; PMID:38676876; PMID:38723480; PMID:38881217; PMID:38909693 |
| GO:0070995 | Nadph oxidation | Decreases phenotype | PMID:24295472 |
| GO:0071243 | Cellular response to arsenic-containing substance | Increases phenotype | PMID:23070617; PMID:24239724; PMID:27056082; PMID:28615018; PMID:35547012; PMID:37759824 |
| GO:0071442 | Positive regulation of histone h3-k14 acetylation | Increases phenotype | PMID:27068294 |
| GO:0071480 | Cellular response to gamma radiation | Affects phenotype | PMID:31769258 |
| GO:0071722 | Detoxification of arsenic-containing substance | Increases phenotype | PMID:23070617; PMID:24845704; PMID:27056082; PMID:35088608 |
| GO:0071897 | Dna biosynthetic process | Decreases phenotype | PMID:17450239 |
| GO:0072089 | Stem cell proliferation | Decreases phenotype | PMID:38299738 |
| GO:0072520 | Seminiferous tubule development | Affects phenotype | PMID:33127376; PMID:33127376; PMID:33171135 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:31350662; PMID:31584213; PMID:31739468; PMID:31739468; PMID:33736254; PMID:31822296; PMID:32006662; PMID:32525701; PMID:33063558; PMID:33497711; PMID:33736254; PMID:35351628; PMID:35351628; PMID:35777461; PMID:35714946; PMID:35821281; PMID:36117518; PMID:37730986; PMID:37879473; PMID:38065500 |
| GO:0072660 | Maintenance of protein location in plasma membrane | Affects phenotype | PMID:31398423 |
| GO:0072676 | Lymphocyte migration | Increases phenotype | PMID:39317010 |
| GO:0080009 | Mrna methylation | Increases phenotype | PMID:38723480 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:38299738 |
| GO:0090136 | Epithelial cell-cell adhesion | Decreases phenotype | PMID:38881217 |
| GO:0090181 | Regulation of cholesterol metabolic process | Affects phenotype | PMID:26068977 |
| GO:0090207 | Regulation of triglyceride metabolic process | Affects phenotype | PMID:26068977 |
| GO:0097198 | Histone h3-k36 trimethylation | Decreases phenotype | PMID:29499398 |
| GO:0097215 | Negative regulation of lysosomal membrane permeability | Increases phenotype | PMID:36117518 |
| GO:0097368 | Establishment of sertoli cell barrier | Affects phenotype | PMID:37084658 |
| GO:0097676 | Histone h3-k36 dimethylation | Affects phenotype | PMID:26967670 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:33410021; PMID:34352348; PMID:36757007; PMID:36813806; PMID:38798119 |
| GO:0098532 | Histone h3-k27 trimethylation | Decreases phenotype | PMID:38299738 |
| GO:0098609 | Cell-cell adhesion | Increases phenotype | PMID:33047385 |
| GO:0099156 | Cell-cell signaling via exosome | Increases phenotype | PMID:30169766 |
| GO:0106106 | Cold-induced thermogenesis | Decreases phenotype | PMID:32045263 |
| GO:0110090 | Positive regulation of hippocampal neuron apoptotic process | Increases phenotype | PMID:35993674 |
| GO:0120327 | Telopode | Decreases phenotype | PMID:35378173 |
| GO:0140042 | Lipid droplet formation | Affects phenotype | PMID:33736254; PMID:36463740; PMID:37879473; PMID:39317010 |
| GO:0140059 | Dendrite arborization | Decreases phenotype | PMID:35993674 |
| GO:0140409 | Positive regulation of mrna alternative polyadenylation | Increases phenotype | PMID:37021545 |
| GO:0140644 | Neutrophil extracellular trap | Increases phenotype | PMID:33063558 |
| GO:0140657 | Atp-dependent activity | Decreases phenotype | PMID:25062976; PMID:36947368 |
| GO:1900111 | Positive regulation of histone h3-k9 dimethylation | Increases phenotype | PMID:27068294 |
| GO:1901052 | Sarcosine metabolic process | Affects phenotype | PMID:33736254 |
| GO:1901605 | Alpha-amino acid metabolic process | Affects phenotype | PMID:25577196 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:24295472 |
| GO:1901687 | Glutathione derivative biosynthetic process | Decreases phenotype | PMID:24295472 |
| GO:1901896 | Positive regulation of atpase-coupled calcium transmembrane transporter activity | Decreases phenotype | PMID:24295472 |
| GO:1902465 | Negative regulation of histone h3-k27 trimethylation | Increases phenotype | PMID:22843710 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:24295472 |
| GO:1902958 | Positive regulation of mitochondrial electron transport, nadh to ubiquinone | Decreases phenotype | PMID:24295472 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:34364923; PMID:35809665; PMID:36162444 |
| GO:1903220 | Positive regulation of malate dehydrogenase (decarboxylating) (nadp+) activity | Decreases phenotype | PMID:24295472 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:38423337 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Decreases phenotype | PMID:24295472 |
| GO:1903408 | Positive regulation of p-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:24295472 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:29741077 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:24295472; PMID:24348802; PMID:32007923; PMID:32159786 |
| GO:1903543 | Positive regulation of exosomal secretion | Increases phenotype | PMID:30169766 |
| GO:1903561 | Extracellular vesicle | Increases phenotype | PMID:34044057 |
| GO:1903841 | Cellular response to arsenite(3-) | Increases phenotype | PMID:21560223 |
| GO:1903936 | Cellular response to sodium arsenite | Decreases phenotype | PMID:36504884 |
| GO:1904026 | Regulation of collagen fibril organization | Affects phenotype | PMID:38310360 |
| GO:1904231 | Positive regulation of succinate dehydrogenase activity | Decreases phenotype | PMID:24295472 |
| GO:1904263 | Positive regulation of torc1 signaling | Increases phenotype | PMID:29248574 |
| GO:1904356 | Regulation of telomere maintenance via telomere lengthening | Affects phenotype | PMID:29757418 |
| GO:1904358 | Positive regulation of telomere maintenance via telomere lengthening | Increases phenotype | PMID:25460668 |
| GO:1904960 | Positive regulation of cytochrome-c oxidase activity | Decreases phenotype | PMID:24295472 |
| GO:1905517 | Macrophage migration | Increases phenotype | PMID:30889423 |
| GO:1905603 | Regulation of blood-brain barrier permeability | Decreases phenotype | PMID:20829427 |
| GO:1905867 | Epididymis development | Affects phenotype | PMID:33171135 |
| GO:1990773 | Matrix metallopeptidase secretion | Increases phenotype | PMID:23232971; PMID:26637202 |
| GO:2000147 | Positive regulation of cell motility | Decreases phenotype | PMID:25868784 |
| GO:2000555 | Negative regulation of t-helper 1 cell cytokine production | Increases phenotype | PMID:24924402 |
| GO:2000617 | Positive regulation of histone h3-k9 acetylation | Increases phenotype | PMID:21385672 |
| GO:2001162 | Positive regulation of histone h3-k79 methylation | Increases phenotype | PMID:29161537 |
| GO:2001255 | Positive regulation of histone h3-k36 trimethylation | Increases phenotype | PMID:27068294 |
| GO:2001272 | Positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | Increases phenotype | PMID:35993674 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.